SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company specializing in data-driven medicine, has announced the release date for its second quarter 2024 financial results. The results will be unveiled on August 6, 2024, before U.S. markets open. Following the release, the company will host a conference call at 8:00 a.m. EDT / 2:00 p.m. CET to discuss the financial results and provide a business outlook. Investors and interested parties can access the webcast live on the SOPHiA GENETICS Investor Relations Website, where a replay will also be available after the call.

News Market Reaction

-2.95%

1 alert

-2.95% News Effect

On the day this news was published, SOPH declined 2.95%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

07/23/2024 - 06:45 AM

BOSTON and ROLLE, Switzerland, July 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal year 2024 before U.S. markets open on Tuesday, August 6, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data – including genomics, radiomics, clinical, biological, and digital pathology data – to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-second-quarter-2024-on-august-6-2024-302203216.html

SOURCE SOPHiA GENETICS

FAQ

When will SOPHiA GENETICS (SOPH) release its Q2 2024 financial results?

SOPHiA GENETICS (SOPH) will release its Q2 2024 financial results on August 6, 2024, before U.S. markets open.

What time is SOPHiA GENETICS' Q2 2024 earnings call scheduled for?

SOPHiA GENETICS' Q2 2024 earnings call is scheduled for August 6, 2024, at 8:00 a.m. EDT / 2:00 p.m. CET.

Where can I access SOPHiA GENETICS' (SOPH) Q2 2024 earnings call?

The earnings call will be webcast live on the SOPHiA GENETICS Investor Relations Website. A replay will also be available on the website after the call.